Opportunity Information: Apply for RFA HG 25 007
The "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" funding opportunity (RFA HG 25 007) is a National Institutes of Health (NIH) cooperative agreement run through the National Human Genome Research Institute (NHGRI). It sits under NHGRI's renewal of the Human Genome Reference Program (HGRP) and is focused on accelerating real-world adoption of an improved pangenome reference. In practical terms, the program wants to fund teams that will build and deliver informatics tools that make it easier for researchers, clinicians, and other genomics users to work with pangenome-based references, especially as the field shifts from relying on a single linear reference genome toward graph-based or multi-genome representations that better capture human genetic diversity.
The core goal is tool development that supports common, high-impact use cases across major genomics sectors, including clinical genomics, population genomics, and functional genomics. The emphasis is not just on theoretical methods, but on tools that enable uptake and routine use of the pangenome reference by a broad community. The opportunity highlights examples of the kinds of tools NHGRI is interested in: software that can choose an appropriate subset of linear genomes or identify paths through a pangenome graph tailored to a specific sample set; visualization approaches that help users interpret complex variation that does not fit neatly into traditional linear-reference frameworks; and annotation tools that connect variants and regions in the pangenome to regulatory elements, functional effects, and disease associations. Overall, the intent is to lower technical barriers and improve interoperability so that pangenome resources can plug into real pipelines for analysis, interpretation, and downstream decision-making.
This opportunity uses the U01 mechanism, which is a cooperative agreement rather than a standard research grant. That generally means awardees should expect more active NIH involvement than with an R01, such as substantial programmatic coordination, milestone-driven progress, and collaboration expectations across funded projects or broader HGRP activities. The notice explicitly states "Clinical Trial Not Allowed," so proposals should be structured as informatics tool development and validation efforts, not as clinical trials.
In terms of funding details provided in the source, the award ceiling is listed as $400,000, and the NOFO indicates that multiple awards are expected (the exact number is not specified in the provided text). The original closing date is March 3, 2025, and the opportunity was created on December 6, 2024. The activity categories associated with the opportunity include Education and Health, and the CFDA/assistance listing numbers provided include 93.172, 93.393, 93.394, 93.395, 93.396, 93.399, and 93.866.
Eligibility is broad and includes many types of organizations that commonly apply for NIH funding. Eligible applicants listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also calls out additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and non-U.S. entities (foreign organizations). This wide eligibility aligns with the program's community-oriented goal: to build tools that serve diverse users and to encourage participation from a broad range of institutions.
Taken together, this NOFO is essentially a targeted push to ensure the pangenome reference becomes usable infrastructure rather than a niche resource. Strong applications will likely focus on clearly defined user needs, practical tool design, compatibility with existing genomics workflows, and deliverables that make pangenome data easier to select, navigate, visualize, and annotate for research and clinical-adjacent interpretation, without crossing into clinical trial activity.Apply for RFA HG 25 007
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172, 93.393, 93.394, 93.395, 93.396, 93.399, 93.866.
- This funding opportunity was created on 2024-12-06.
- Applicants must submit their applications by 2025-03-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" and is identified as RFA HG 25 007.
Which agency is offering this opportunity?
This is a National Institutes of Health (NIH) funding opportunity run through the National Human Genome Research Institute (NHGRI).
What broader program does this NOFO fall under?
It sits under NHGRI's renewal of the Human Genome Reference Program (HGRP) and supports efforts to accelerate adoption of an improved pangenome reference.
What is the overall purpose of this opportunity?
The purpose is to fund teams to build and deliver informatics tools that make it easier for the genomics community to use pangenome-based references in real workflows, as the field transitions from a single linear reference genome to graph-based or multi-genome representations that better reflect human genetic diversity.
What kinds of projects is NHGRI trying to fund?
The focus is informatics tool development that supports common, high-impact use cases across major genomics sectors. The emphasis is on practical tools that enable broad uptake and routine use of the pangenome reference, not just theoretical or conceptual methods.
Which genomics sectors or use cases are specifically mentioned?
The opportunity highlights tool development supporting clinical genomics, population genomics, and functional genomics.
What are examples of tools or capabilities NHGRI is interested in supporting?
Examples called out include: (1) software that can choose an appropriate subset of linear genomes or identify paths through a pangenome graph tailored to a specific sample set; (2) visualization approaches to help users interpret complex variation that does not fit neatly into traditional linear-reference frameworks; and (3) annotation tools that connect variants and regions in the pangenome to regulatory elements, functional effects, and disease associations.
Is the program focused on interoperability and integration with existing pipelines?
Yes. A stated intent is to lower technical barriers and improve interoperability so pangenome resources can plug into real pipelines for analysis, interpretation, and downstream decision-making.
What award mechanism is being used?
The opportunity uses the U01 mechanism, which is a cooperative agreement (not a standard research grant mechanism like an R01).
What does it mean that this is a cooperative agreement (U01)?
As described in the opportunity summary, awardees should expect more active NIH involvement than with a standard research grant, including substantial programmatic coordination, milestone-driven progress, and collaboration expectations across funded projects or broader HGRP activities.
Are clinical trials allowed under this NOFO?
No. The notice explicitly states "Clinical Trial Not Allowed," so applications should be framed as informatics tool development and validation efforts rather than clinical trials.
How much funding is available per award?
The award ceiling listed is $400,000.
Will NIH make multiple awards?
Yes. The NOFO indicates multiple awards are expected, though the exact number is not specified in the provided information.
What is the closing date?
The original closing date is March 3, 2025.
When was this opportunity created?
The opportunity was created on December 6, 2024.
Who is eligible to apply?
Eligibility is broad and includes many organization types, including: state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses.
Are minority-serving institutions and community-based organizations included in eligibility?
Yes. The eligible categories listed also include Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); and faith-based or community-based organizations.
Are federal agencies or regional organizations eligible?
Yes. The eligibility list includes eligible federal agencies and regional organizations.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are included in the listed eligible applicant categories.
Are foreign (non-U.S.) organizations eligible to apply?
Yes. Non-U.S. entities (foreign organizations) are explicitly listed as eligible applicants.
What activity categories are associated with this opportunity?
The activity categories associated with the opportunity include Education and Health.
What assistance listing (CFDA) numbers are associated with this opportunity?
The CFDA/assistance listing numbers provided are 93.172, 93.393, 93.394, 93.395, 93.396, 93.399, and 93.866.
What is the main shift in genomics that this NOFO is responding to?
It responds to the field shifting from relying on a single linear reference genome toward graph-based or multi-genome pangenome representations that better capture human genetic diversity, and it aims to make that shift practical for everyday users.
What would a strong application likely emphasize?
Based on the stated intent, strong applications would likely emphasize clearly defined user needs, practical tool design, compatibility with existing genomics workflows, and concrete deliverables that make pangenome data easier to select, navigate, visualize, and annotate for research and clinical-adjacent interpretation, without crossing into clinical trial activity.
Browse more opportunities from the same category: Education, Health
Next opportunity: U.S. Embassy Yangon Public Diplomacy Small Grants Competition
Previous opportunity: Ambassadors Fund for Cultural Preservation
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HG 25 007
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HG 25 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Apply for PAR 25 321 Funding Number: PAR 25 321 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Apply for PAR 25 346 Funding Number: PAR 25 346 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) Apply for RFA AA 24 012 Funding Number: RFA AA 24 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) Apply for PAR 25 317 Funding Number: PAR 25 317 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Apply for PAR 25 325 Funding Number: PAR 25 325 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Apply for PAS 25 236 Funding Number: PAS 25 236 Agency: National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 25 003 Funding Number: RFA CA 25 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 25 001 Funding Number: RFA CA 25 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 25 004 Funding Number: RFA CA 25 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 25 002 Funding Number: RFA CA 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) Apply for PAR 25 336 Funding Number: PAR 25 336 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) Apply for RFA CA 25 019 Funding Number: RFA CA 25 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Apply for PAR 25 101 Funding Number: PAR 25 101 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 074 Funding Number: RFA DA 25 074 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 25 005 Funding Number: RFA CA 25 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 25 007 Funding Number: RFA CA 25 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 25 006 Funding Number: RFA CA 25 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Apply for PAR 25 337 Funding Number: PAR 25 337 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,000 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) Apply for PAR 25 338 Funding Number: PAR 25 338 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,000 |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) Apply for PAR 25 347 Funding Number: PAR 25 347 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 25 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
